SELective defunctioning Stoma Approach in low anterior resection for rectal cancer (SELSA): Protocol for a prospective study with a nested randomized clinical trial investigating stoma‐free survival without major LARS following total mesorectal excision
Colorectal Disease · 2025-02 · 27 (2)
DOI: 10.1111/codi.70009 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Colorectal Disease, online erschienen am 30.01.2025. Verfasst von Martin Rutegård und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostics and Intervention, Surgery, Umeå University, Umeå, Sweden. Hauptthemen laut MEDLINE: Anastomotic Leak, Proctectomy, Rectal Neoplasms, Surgical Stomas. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Research Council, Cancerfonden, Vetenskapsrådet.
Abstract (Originalsprache)
Aim
Accumulated data suggest that routine use of defunctioning stoma in low anterior resection for rectal cancer may cause kidney injury, bowel dysfunction and a higher risk of permanent stomas. We aim to study whether avoidance of a diverting stoma in selected patients is safe and reduces adverse consequences.
Methods
SELSA is a multicentre international prospective observational study nesting an open‐label randomized clinical trial. All patients with primary rectal cancer planned for low anterior resection are eligible. Patients operated with curative intent, aged
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Diagnostics and Intervention, Surgery, Umeå University, Umeå, Sweden.
- Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden.
- Department of Surgery, Ryhov County Hospital, Jönköping, Sweden.
- Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
- Department of Surgery, Faculty of Medicine and Health Sciences, Örebro University, Örebro, Sweden.
- Department of Gastrointestinal Surgery, Haukeland University Hospital, Bergen, Norway.
ORCID-Profile: Martin Rutegård, Marcus Lindsköld, Fredrik Jörgren, Kalle Landerholm, Peter Matthiessen, Håvard Mjørud Forsmo, Jennifer Park, Jacob Rosenberg, Johannes Schultz, Lars T Seeberg, Josefin Segelman, Pamela Buchwald
Förderung
- Swedish Research Council
- Cancerfonden
- Vetenskapsrådet
Zitieren
APA
Rutegård, M., Lindsköld, M., Jörgren, F., Landerholm, K., Matthiessen, P., Forsmo, H. M., Park, J., Rosenberg, J., Schultz, J., Seeberg, L. T., Segelman, J., & Buchwald, P. (2025). SELective defunctioning Stoma Approach in low anterior resection for rectal cancer (SELSA): Protocol for a prospective study with a nested randomized clinical trial investigating stoma‐free survival without major LARS following total mesorectal excision. Colorectal Disease, 27(2). https://doi.org/10.1111/codi.70009
Vancouver
Rutegård M, Lindsköld M, Jörgren F, Landerholm K, Matthiessen P, Forsmo HM, et al. SELective defunctioning Stoma Approach in low anterior resection for rectal cancer (SELSA): Protocol for a prospective study with a nested randomized clinical trial investigating stoma‐free survival without major LARS following total mesorectal excision. Colorectal Disease. 2025;27(2). doi:10.1111/codi.70009
BibTeX
@article{Rutegrd2025,
author = {Rutegård, Martin and Lindsköld, Marcus and Jörgren, Fredrik and Landerholm, Kalle and Matthiessen, Peter and Forsmo, Håvard Mjørud and Park, Jennifer and Rosenberg, Jacob and Schultz, Johannes and Seeberg, Lars T and Segelman, Josefin and Buchwald, Pamela},
title = {SELective defunctioning Stoma Approach in low anterior resection for rectal cancer (SELSA): Protocol for a prospective study with a nested randomized clinical trial investigating stoma‐free survival without major LARS following total mesorectal excision},
journal = {Colorectal Disease},
year = {2025},
volume = {27},
number = {2},
doi = {10.1111/codi.70009}
}
EUVIMED